New to telehealth and telemedicine? Interested in a high overview of digital health in general. Learn basic definitions, applications, and technology when it comes to telehealth. 

Read on learntelehealth.org

Dear Colleagues,

On behalf of the organizing committee, we are delighted to invite you to the "Mayo Clinic - SSMC Transfusion Medicine Update Conference" to be held on 18th-19th of November 2022, at Grand Hyatt Hotel in Abu Dhabi, UAE.

The program is designed to deliver updates in the field of blood banking, blood donation, apheresis and cellular therapies.

This conference targets all medical professional; including physicians, nurses, scientists, and medical technologists.

The two days event will bring together the foremost thought leaders and experts in transfusion medicine from the USA, Europe, the GCC region, and the UAE to present data on multiple topics, including the latest developments in clinical transfusion medicine, laboratory practices, immunohematology, donor and blood supply, patient safety, cellular therapies and the latest updates in Apheresis.

To make this a complete scientific experience, great care is being taken to design a comprehensive program in consultation with a renowned faculty from the field. The meeting will offer a superb opportunity for physicians, medical specialists and all healthcare professionals to attend expert updates and to share and exchange best practices, knowledge and experiences and to network with new and established colleagues, creating and strengthening clinical collaborations.

This meeting will promise you the highest quality of scientific, and educational opportunities. It also provides the best networking platform with colleagues, both national and international, while expanding existing connections or creating new ones.

Let's meet in November 2022 with the most magnificent gatherings around the region that provides an assertion to discover the latest knowledge and innovations in the field of Transfusion Medicine.

We are very much looking forward to welcoming you all at the conference.

Time: 08:00 to 17:00

Biomarker quantification plays an integral role in the drug development process, providing guidance for downstream decision-making that has shown to correlate positively with clinical trial success. Biomarker-based stratification enriches clinical populations, reducing cost and trial duration. However, the real value of biomarker insights have not been fully realized due the limitations in the development and implementation of effective biomarker strategies in many clinical programmes across therapeutic areas, resulting in the absence of predictive biomarkers in the latest drug approvals. It is also worth considering the prospect of applying machine-learning to biomarker assessment, which promises improved patient stratification of treatment response to drive drug development.

Read on xtalks.com

The synthesis of long helical oligoamide foldamers composed of more than 20 aromatic monomers of 8-amino-2-quinoline carboxylic acid can now be routinely achieved by using an in lab-developed solid-phase foldamer synthesis (SPFS) methodology that relies on acid chloride activation. aThe automation of the SPFS conditions is revolutionizing the production of high molecular weight aromatic oligoamides with very good yield and purity and faster production compared to the manual approach. That constitutes a critical milestone in the field of aromatic foldamer chemistry with many concrete applications such as the modulation of protein-protein interactions in competitive research programs.

Read on xtalks.com

This All-on-Sales Conference will provide doctors and their team members with proven, tangible tactics and case presentation strategies to supercharge All-on-X case acceptance. Learn how to integrate proven methodologies into your system from the experts. This comprehensive, two-day conference will emphasize a competitive approach to attract and close large-dollar dental implant cases. Clinical best practices in successfully treating All-on-X cases will also be presented. For best results, doctors and team members should attend this training together.

Read on allonxsales.com

The NHS Innovation Conference is our most followed and attended event, having welcomed over 2500 NHS IT and innovation leaders through its series. We are proud to show continued support to the NHS and provide complimentary attendance to the sector, take a look at our next addition below:

This event has been developed exclusively for NHS innovators and secondary care leaders, the thought-provoking agenda provides a timely platform to listen learn and engage with some of the UK’s most reputable professionals from across both the NHS and Industry.

Key talking points:

• Investing in diagnostics: The transforming diagnostics funding
• Empowering patients and overcoming digital literacy issues
• Implementing a digital culture: Workforce of the future
• Emerging technology: Hype or Help?

Read on convenzis.co.uk

In today’s digital world, data is king, and the future is in robust systems and processes that ensure data integrity and value. Within the clinical trial industry, data is collected in many formats, and it must be filtered and managed to be useful. Controlling how it is stored, accessed and ultimately used is all part of assuring data reliability and protecting the safety of patients and the quality of the drugs created. In this webinar, the featured speakers will talk all things data - how it’s relevance and accessibility has flourished, how it’s shaping the clinical trial industry and the expected growth of data strategy as technologies and the roles in data management evolve.

Read on xtalks.com

The goal of this focus group will be to explore how IT leaders are meeting a rise of consumerism in healthcare through the adoption of digital technologies and more patient centric workflows. We will discuss the most pressing digital patient experience priorities, strategies to improve the efficiency of non-clinical staff and the top evaluation criteria for new technology partners.

Read on chimecentral.org

Precision medicine is deeply transforming healthcare by tailoring care precisely to the individual. This exacting approach to care is leveraging data, genomics, and increasing interoperability to help clinicians identify the most appropriate, cost-effective treatments, and even spot previously undetected causes of disease. The aim of the “Precision Medicine Webinar” is to gather senior level executives from pharmaceutical and biotechnology companies and discuss during this full-day conference the current trends and challenges in the precision medicine industry.

Read on ubiqwebinars.com

Advanced therapy medicinal products or ATMPs, are among the fastest growing areas of biotherapeutics, encompassing gene therapies, viral therapies, vaccines and cell therapies. The control strategies are very different from more traditional biologics, with quantitation of potency posing one of the greatest challenges. In this webinar, representative case studies will demonstrate considerations in the conception, development and validation of potency assays - mostly cell-based - for representative ATMPs. The use of different analytical technologies and complex assay schema will be provided along with consideration of timing, phase-appropriate validation (qualification) considerations and assay lifecycle guidance as the product moves through the clinical development phases. Topics for discussion will include data and statistical considerations and how data may be processed to extract relevant insights and monitor attributes such as relative potency. The implications of global regulatory guidance and precedence will also be discussed.

Read on xtalks.com